Pharmacovigilance study and development of a clinical decision flowchart for personalized selection of trastuzumab, T-DXd, and T-DM1 in breast cancer patients

View at publisher
Authors: Xiaohu Yang, Xiaomei Pei, Chunli Song, Lingti Kong
Cited by: 2
References: 44

Fields of Study & Subjects

HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
Clinical & Translational Oncology
Publisher
Springer Science and Business Media LLC
Volume
28
Issue
6
Pages
2118–2134
Publication date
10 January 2026
Language
EN